You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Newly diagnosed epilepsy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 1 Diabetes Trial in Sacramento (personalized comprehensive diabetes support)

Enrolling by invitation
  • Type 1 Diabetes
  • personalized comprehensive diabetes support
  • Sacramento, California
    University of California Davis
Sep 24, 2023

Newly Diagnosed Glioblastoma Trial ([177Lu]Lu-NeoB, [68Ga]Ga-NeoB, Temozolomide)

Not yet recruiting
  • Newly Diagnosed Glioblastoma
  • (no location specified)
Feb 13, 2023

AI-ECG in a NEwly Diagnosed Heart Failure

Recruiting
  • Heart Failure
  • Eko DUO
  • London, United Kingdom
    Imperial College London
Apr 4, 2023

Positron Emission Radiomics With PSMA Radioligands on Newly

Not yet recruiting
  • Prostate Cancer
  • Immunohistochemistry (IHC) analysis
  • (no location specified)
Apr 6, 2023

Extensive Small Cell Lung Cancer Trial in Jinan (Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy)

Recruiting
  • Extensive Small Cell Lung Cancer
  • Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy
  • Jinan, Shan Dong, China
    The First Affiliated Hospital of Shandong First Medical Universi
Nov 6, 2023

Type 2 Diabetes Trial in Roma (flash glucose monitoring continuous, capillary blood test, flash glucose monitoring intermittent)

Recruiting
  • Type 2 Diabetes
  • flash glucose monitoring continuous
  • +2 more
  • Roma, Italy
    Fondazione Policlinico Universitario Campus Bio-Medico
Oct 18, 2023

Breast Cancer Stage IV Trial in Vienna (Datopotamab deruxtecan)

Recruiting
  • Breast Cancer Stage IV
  • Datopotamab deruxtecan
  • Vienna, Austria
    AKH Universitaetsklinikum Vienna, Department f. Internal medicin
May 19, 2023

Ovarian Cancer Trial in Birmingham (Carboplatin, olaparibp, embro)

Not yet recruiting
  • Ovarian Cancer
  • Birmingham, Alabama
    O'Neal Comprehensive Cancer Center at UAB
Jul 18, 2023

Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)

Recruiting
  • Glioblastoma
  • +3 more
  • Adaptive Radiotherapy
  • New York, New York
    Columbia University Irving Medical Center
Oct 27, 2023

Large B-cell Lymphoma Trial in Houston (Prednisone, Rituximab, Cyclophosphamide)

Not yet recruiting
  • Large B-cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 19, 2023

Newly-diagnosed PCNSL Treated WithMethotrexate and

Active, not recruiting
  • Primary Central Nervous System Lymphoma
  • Shanghai, China
    Department of Hematology, Huashan Hospital, Fudan University
Oct 30, 2023

Newly Diagnosed MGMT Unmethylated Glioblastoma Trial in Durham (D2C7-IT, 2141-V11)

Not yet recruiting
  • Newly Diagnosed MGMT Unmethylated Glioblastoma
  • Durham, North Carolina
    Duke University Medical Center
Feb 7, 2023

Waldenström's Macroglobulinemia Trial (zanubrutinib,bendamustine,rituximab)

Not yet recruiting
  • Waldenström's Macroglobulinemia
  • (no location specified)
Aug 4, 2023

Diffuse Large B Cell Lymphoma Trial in Shenyang (Zanubrutinib, Rituximab, Cyclophosphamide)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Shenyang, Liaoning, China
    Xing Xiaojing
Jun 1, 2023

DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))

Recruiting
  • DLBCL - Diffuse Large B Cell Lymphoma
  • Follicular Lymphoma
  • Lenalidomide combined with G-CHOP (LO CHOP)
  • Xiamen, Fujian, China
    Bing Xu
Nov 28, 2023

Stem Cells Mobilization, colLection and Engraftment in Newly

Recruiting
  • Multiple Myeloma
  • +3 more
  • Rome, Italy
    Fondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023

Non Severe Aplastic Anemia Trial in Beijing (Romiplostim, Ciclosporin)

Not yet recruiting
  • Non Severe Aplastic Anemia
  • Beijing, China
    Peking union medical college hospital
Aug 18, 2023

Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme Trial in Cleveland (Eflornithine (Dose Level 1), Eflornithine

Recruiting
  • Glioblastoma, IDH-wildtype
  • +4 more
  • Eflornithine (Dose Level 1)
  • +3 more
  • Cleveland, Ohio
    The Cleveland Clinic
May 19, 2023

Glioblastoma Trial (Gabapentin, Sulfasalazine, Memantine)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Dec 15, 2022

Multiple Myeloma, Renal Failure Trial in Augusta (Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide,

Not yet recruiting
  • Multiple Myeloma
  • Renal Failure
  • Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone
  • Augusta, Georgia
    Georgia Cancer Center-Augusta University
Nov 16, 2023

Asthma (Diagnosis) Trial in Zagazig (Fibreoptic bronchoscopy)

Completed
  • Asthma (Diagnosis)
  • Fibreoptic bronchoscopy
  • Zagazig, Egypt
    Chest Department,Faculty of Medicine
Mar 8, 2023

Multiple Myeloma, New Diagnosis Tumor Trial in Hangzhou (BCMA CAR-T cells)

Recruiting
  • Multiple Myeloma
  • New Diagnosis Tumor
  • BCMA CAR-T cells
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Jan 31, 2023

Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma Trial in Padova (Regorafenib, Temozolomide)

Recruiting
  • Glioblastoma, IDH-wildtype
  • MGMT-Methylated Glioblastoma
  • Padova, Italy
    Istituto Oncologico Veneto IRCCS
Oct 18, 2023

Glioblastoma, IDH-wildtype Trial in Beijing (Elemene, Placebo)

Not yet recruiting
  • Glioblastoma, IDH-wildtype
  • Beijing, China
    Peking Union Medical College Hospital
Apr 22, 2023

Classical Hodgkin Lymphoma Trial in Guangzhou (Zimberelimab 240mg)

Recruiting
  • Classical Hodgkin Lymphoma
  • Zimberelimab 240mg
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-Sen University Cancer Ce
Jun 15, 2023